Literature DB >> 15577295

Use of medication during pregnancy and risk of childhood leukemia (Canada).

Amanda K Shaw1, Claire Infante-Rivard, Howard I Morrison.   

Abstract

OBJECTIVE: To examine risk of childhood acute lymphoblastic leukemia (ALL) associated with maternal use of medications during pregnancy; in particular medications known or suspected to be teratogenic.
METHODS: Seven hundred and eighty nine children (< 15 years old) diagnosed with ALL in the province of Quebec between 1980 and 2000 were recruited for study. A similar number of population based controls matched to cases (1:1) by sex and age were chosen from family allowance or health insurance files. Information was gathered via telephone interview with the subjects' parents. Data were analyzed using conditional logistic regression.
RESULTS: Risk of childhood ALL was significantly increased in the offspring of mothers who reported using any medication (adjusted odds ratio (OR(adj)) = 1.3, 95% CI = 1.0-1.6) or any teratogenic medication (OR(adj) = 1.4, 95% CI = 1.1-1.9) during pregnancy. Among specific medication categories, only central nervous system depressants were associated with a significantly increased risk, although elevated odd ratios were found for anti-epileptics, immunosuppressants, oral contraceptives, and illicit drugs. Risk associated with use of teratogenic medications was higher with increased dose and in children diagnosed before two years of age.
CONCLUSION: A modest increase in risk of ALL was found among children of mothers who used medication during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15577295     DOI: 10.1007/s10552-004-2230-6

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  7 in total

Review 1.  The Protective Effect of Maternal Folic Acid Supplementation on Childhood Cancer: A Systematic Review and Meta-analysis of Case-control Studies.

Authors:  Wan Rosmawati Wan Ismail; Raudah Abdul Rahman; Nur Ashiqin Abd Rahman; Azman Atil; Azmawati Mohammed Nawi
Journal:  J Prev Med Public Health       Date:  2019-07-02

2.  Infant leukemia and parental infertility or its treatment: a Children's Oncology Group report.

Authors:  Susan E Puumala; Logan G Spector; Melanie M Wall; Leslie L Robison; Nyla A Heerema; Michelle A Roesler; Julie A Ross
Journal:  Hum Reprod       Date:  2010-04-10       Impact factor: 6.918

Review 3.  Maternal antibiotics exposure during pregnancy and the risk of acute lymphoblastic leukemia in childhood: a systematic review and meta-analysis.

Authors:  Xiaolin Zhu; Ying Meng; Yang Yang; Ningning Feng
Journal:  Eur J Pediatr       Date:  2021-09-17       Impact factor: 3.183

4.  Maternal supplementation with folic acid and other vitamins and risk of leukemia in offspring: a Childhood Leukemia International Consortium study.

Authors:  Catherine Metayer; Elizabeth Milne; John D Dockerty; Jacqueline Clavel; Maria S Pombo-de-Oliveira; Catharina Wesseling; Logan G Spector; Joachim Schüz; Eleni Petridou; Sameera Ezzat; Bruce K Armstrong; Jérémie Rudant; Sergio Koifman; Peter Kaatsch; Maria Moschovi; Wafaa M Rashed; Steve Selvin; Kathryn McCauley; Rayjean J Hung; Alice Y Kang; Claire Infante-Rivard
Journal:  Epidemiology       Date:  2014-11       Impact factor: 4.822

5.  Medication use during pregnancy and the risk of childhood cancer in the offspring.

Authors:  Joachim Schüz; Thomas Weihkopf; Peter Kaatsch
Journal:  Eur J Pediatr       Date:  2007-03-08       Impact factor: 3.183

6.  Analgesic use during pregnancy and risk of infant leukaemia: a Children's Oncology Group study.

Authors:  S Ognjanovic; C Blair; L G Spector; L L Robison; M Roesler; J A Ross
Journal:  Br J Cancer       Date:  2010-12-14       Impact factor: 7.640

7.  Vitamin and mineral supplements in pregnancy and the risk of childhood acute lymphoblastic leukaemia: a case-control study.

Authors:  John D Dockerty; Peter Herbison; David C G Skegg; Mark Elwood
Journal:  BMC Public Health       Date:  2007-07-03       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.